Citation 1:
    Title: Eli Lilly and Company (LLY) stock historical prices and data – Yahoo Finance
    URL: https://uk.finance.yahoo.com/quote/LLY/history/#:~:text=7%20May%202025%20%20,12%2C601%2C100
    Location: chars 100–217

Citation 2:
    Title: Eli Lilly and Company (LLY) Stock Price, News, Quote & History - Yahoo Finance
    URL: https://finance.yahoo.com/quote/LLY/#:~:text=Sector
    Location: chars 455–529

Citation 3:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=,to%20%245.32
    Location: chars 1008–1178

Citation 4:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=,00
    Location: chars 1388–1548

Citation 5:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=The%20company%20anticipates%202025%20revenue,indications%20for%20existing%20Lilly%20medicines
    Location: chars 1549–1799

Citation 6:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=Q4%202023.%20,to%20%245.32
    Location: chars 2058–2241

Citation 7:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance - BioSpace
    URL: https://www.biospace.com/press-releases/lilly-reports-full-q4-2024-financial-results-and-provides-2025-guidance#:~:text=,increase%20in%20Lilly%27s%20quarterly%20dividend
    Location: chars 2242–2433

Citation 8:
    Title: lly-20241231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm#:~:text=Net%20Cash%20Provided%20by%20Operating,
    Location: chars 2479–2625

Citation 9:
    Title: Top pharmaceutical companies by P/E ratio
    URL: https://companiesmarketcap.com/pharmaceuticals/pharmaceutical-companies-ranked-by-pe-ratio/#:~:text=Top%20pharmaceutical%20companies%20by%20P%2FE,ratio
    Location: chars 3130–3309

Citation 10:
    Title: lly-20241231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm#:~:text=Note%2019%3A%20Segment%20Information
    Location: chars 3696–3839

Citation 11:
    Title: lly-20241231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm#:~:text=Note%2019%3A%20Segment%20Information
    Location: chars 3909–4052

Citation 12:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance - BioSpace
    URL: https://www.biospace.com/press-releases/lilly-reports-full-q4-2024-financial-results-and-provides-2025-guidance#:~:text=Total%20Revenue%20%20,34%2C124.1
    Location: chars 4111–4285

Citation 13:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=Mounjaro%20%20,124
    Location: chars 4619–4794

Citation 14:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=Zepbound%20%20,NM
    Location: chars 4833–5007

Citation 15:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=Q4%202023.%20,to%20%245.32
    Location: chars 5569–5752

Citation 16:
    Title: Lilly's new focus: Using incretin therapies in neuro, immunology
    URL: https://www.fiercebiotech.com/biotech/eli-lillys-new-rd-strategy-testing-out-obesity-drugs-neuro-immunology#:~:text=,%E2%80%9D
    Location: chars 5944–6097

Citation 17:
    Title: Lilly and Novo Spend Billions to Expand Obesity Pipelines Beyond GLP-1s - BioSpace
    URL: https://www.biospace.com/business/lilly-and-novo-spend-billions-to-expand-obesity-pipelines-beyond-glp-1s#:~:text=Novo%20Nordisk%20and%20Eli%20Lilly,companies%20are%20raking%20in%20profits
    Location: chars 6664–6874

Citation 18:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance - BioSpace
    URL: https://www.biospace.com/press-releases/lilly-reports-full-q4-2024-financial-results-and-provides-2025-guidance#:~:text=Total%20Revenue%20%20,34%2C124.1
    Location: chars 7421–7595

Citation 19:
    Title: Lilly's new focus: Using incretin therapies in neuro, immunology
    URL: https://www.fiercebiotech.com/biotech/eli-lillys-new-rd-strategy-testing-out-obesity-drugs-neuro-immunology#:~:text=,%E2%80%9D
    Location: chars 7596–7749

Citation 20:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=,to%20%245.32
    Location: chars 7851–8021

Citation 21:
    Title: LLY Economic Moat - Eli Lilly and Co - Alpha Spread
    URL: https://www.alphaspread.com/security/nyse/lly/qualitative/block/economic-moat#:~:text=Eli%20Lilly%20and%20Co%20exhibits,against%20new%20entrants%20and%20competitors
    Location: chars 8296–8485

Citation 22:
    Title: lly-20241231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm#:~:text=Net%20Cash%20Provided%20by%20Operating,
    Location: chars 8538–8684

Citation 23:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance - BioSpace
    URL: https://www.biospace.com/press-releases/lilly-reports-full-q4-2024-financial-results-and-provides-2025-guidance#:~:text=,increase%20in%20Lilly%27s%20quarterly%20dividend
    Location: chars 8748–8939

Citation 24:
    Title: Lilly's new focus: Using incretin therapies in neuro, immunology
    URL: https://www.fiercebiotech.com/biotech/eli-lillys-new-rd-strategy-testing-out-obesity-drugs-neuro-immunology#:~:text=,%E2%80%9D
    Location: chars 9051–9204

Citation 25:
    Title: Top pharmaceutical companies by P/E ratio
    URL: https://companiesmarketcap.com/pharmaceuticals/pharmaceutical-companies-ranked-by-pe-ratio/#:~:text=Top%20pharmaceutical%20companies%20by%20P%2FE,ratio
    Location: chars 9368–9547

Citation 26:
    Title: Lilly and Novo Spend Billions to Expand Obesity Pipelines Beyond GLP-1s - BioSpace
    URL: https://www.biospace.com/business/lilly-and-novo-spend-billions-to-expand-obesity-pipelines-beyond-glp-1s#:~:text=Novo%20Nordisk%20and%20Eli%20Lilly,companies%20are%20raking%20in%20profits
    Location: chars 9774–9984

Citation 27:
    Title: Eli Lilly to cut insulin prices, cap out-of-pocket costs at $35 a month - The Washington Post
    URL: https://www.washingtonpost.com/business/2023/03/01/eli-lilly-insulin/#:~:text=Eli%20Lilly%20said%20it%20is,high%20cost%20of%20diabetes%20care
    Location: chars 10189–10358

Citation 28:
    Title: LLY Economic Moat - Eli Lilly and Co - Alpha Spread
    URL: https://www.alphaspread.com/security/nyse/lly/qualitative/block/economic-moat#:~:text=Eli%20Lilly%20and%20Co%20exhibits,against%20new%20entrants%20and%20competitors
    Location: chars 10847–11036

Citation 29:
    Title: LLY Economic Moat - Eli Lilly and Co - Alpha Spread
    URL: https://www.alphaspread.com/security/nyse/lly/qualitative/block/economic-moat#:~:text=Eli%20Lilly%20and%20Co%20exhibits,against%20new%20entrants%20and%20competitors
    Location: chars 11731–11920

Citation 30:
    Title: Top pharmaceutical companies by P/E ratio
    URL: https://companiesmarketcap.com/pharmaceuticals/pharmaceutical-companies-ranked-by-pe-ratio/#:~:text=Top%20pharmaceutical%20companies%20by%20P%2FE,ratio
    Location: chars 12965–13144

Citation 31:
    Title: lly-20241231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm#:~:text=Eli%20Lilly%20and%20Company%20Shareholders%27,
    Location: chars 14709–14862

Citation 32:
    Title: lly-20241231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm#:~:text=Net%20Cash%20Provided%20by%20Operating,
    Location: chars 14952–15098

Citation 33:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance - BioSpace
    URL: https://www.biospace.com/press-releases/lilly-reports-full-q4-2024-financial-results-and-provides-2025-guidance#:~:text=,increase%20in%20Lilly%27s%20quarterly%20dividend
    Location: chars 15277–15468

Citation 34:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=Q4%202023.%20,to%20%245.32
    Location: chars 15572–15755

Citation 35:
    Title: Eli Lilly to cut insulin prices, cap out-of-pocket costs at $35 a month - The Washington Post
    URL: https://www.washingtonpost.com/business/2023/03/01/eli-lilly-insulin/#:~:text=Eli%20Lilly%20said%20it%20is,high%20cost%20of%20diabetes%20care
    Location: chars 17300–17469

Citation 36:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=,to%20%245.32
    Location: chars 19067–19237

Citation 37:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance | Eli Lilly and Company
    URL: https://investor.lilly.com/news-releases/news-release-details/lilly-reports-full-q4-2024-financial-results-and-provides-2025#:~:text=,00
    Location: chars 19238–19398

Citation 38:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance - BioSpace
    URL: https://www.biospace.com/press-releases/lilly-reports-full-q4-2024-financial-results-and-provides-2025-guidance#:~:text=Total%20Revenue%20%20,34%2C124.1
    Location: chars 19533–19707

Citation 39:
    Title: Lilly reports full Q4 2024 financial results and provides 2025 guidance - BioSpace
    URL: https://www.biospace.com/press-releases/lilly-reports-full-q4-2024-financial-results-and-provides-2025-guidance#:~:text=,increase%20in%20Lilly%27s%20quarterly%20dividend
    Location: chars 19708–19899

Citation 40:
    Title: Lilly's new focus: Using incretin therapies in neuro, immunology
    URL: https://www.fiercebiotech.com/biotech/eli-lillys-new-rd-strategy-testing-out-obesity-drugs-neuro-immunology#:~:text=,%E2%80%9D
    Location: chars 20034–20187

Citation 41:
    Title: Lilly and Novo Spend Billions to Expand Obesity Pipelines Beyond GLP-1s - BioSpace
    URL: https://www.biospace.com/business/lilly-and-novo-spend-billions-to-expand-obesity-pipelines-beyond-glp-1s#:~:text=Novo%20Nordisk%20and%20Eli%20Lilly,companies%20are%20raking%20in%20profits
    Location: chars 20294–20504

Citation 42:
    Title: LLY Economic Moat - Eli Lilly and Co - Alpha Spread
    URL: https://www.alphaspread.com/security/nyse/lly/qualitative/block/economic-moat#:~:text=Eli%20Lilly%20and%20Co%20exhibits,against%20new%20entrants%20and%20competitors
    Location: chars 20587–20776

Citation 43:
    Title: lly-20241231
    URL: https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm#:~:text=Net%20Cash%20Provided%20by%20Operating,
    Location: chars 20866–21012

Citation 44:
    Title: Top pharmaceutical companies by P/E ratio
    URL: https://companiesmarketcap.com/pharmaceuticals/pharmaceutical-companies-ranked-by-pe-ratio/#:~:text=Top%20pharmaceutical%20companies%20by%20P%2FE,ratio
    Location: chars 21092–21271

Citation 45:
    Title: Eli Lilly to cut insulin prices, cap out-of-pocket costs at $35 a month - The Washington Post
    URL: https://www.washingtonpost.com/business/2023/03/01/eli-lilly-insulin/#:~:text=Eli%20Lilly%20said%20it%20is,high%20cost%20of%20diabetes%20care
    Location: chars 21418–21587

